8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
Published . Updated .
Key takeaways
- 8-K - Tonix Pharmaceuticals Holding filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
- Exposed: TNXP
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Tonix Pharmaceuticals Holding filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- TNXP Tonix Pharmaceuticals Holding-26.2% 17d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+2.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.4% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TNXP | +8.34% | +7.92% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| XBI | -0.10% | +4.53% | base | after close | after close | after close | after close |
| LLY | +4.21% | +4.67% | base | after close | after close | after close | after close |
| JNJ | -2.08% | +0.00% | base | after close | after close | after close | after close |
| PFE | +4.51% | +4.78% | base | after close | after close | after close | after close |
| MRK | +1.15% | +2.46% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001493152-26-050621 Size: 311 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Tonix Pharmaceuticals Holding (TNXP) has moved since 9 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | three days earlier | 0.00% | final price |
| JNJ | five days earlier | -2.08% | final price |
| LLY | three days earlier | +4.67% | final price |
| LLY | five days earlier | +4.21% | final price |
| MRK | three days earlier | +2.46% | final price |
| MRK | five days earlier | +1.15% | final price |
| PFE | three days earlier | +4.78% | final price |
| PFE | five days earlier | +4.51% | final price |
| Tonix Pharmaceuticals Holding (TNXP) | three days earlier | +7.92% | final price |
| Tonix Pharmaceuticals Holding (TNXP) | five days earlier | +8.34% | final price |
| XBI | three days earlier | +4.53% | final price |
| XBI | five days earlier | -0.10% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 40 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 62 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 80 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 82 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Tonix Pharmaceuticals Holding (TNXP)
Companies mentioned with this story
- TNXP Tonix Pharmaceuticals Holding
For “8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer),” Tonix Pharmaceuticals Holding (TNXP) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TNXP
Tonix Pharmaceuticals Holding (TNXP)
Tonix Pharmaceuticals Holding (TNXP) is the company in “8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer),” the 9 Nov 2026 this story story.
Tonix Pharmaceuticals Holding (TNXP) is on the page because SEC 8-K filing -> direct issuer disclosure -> TNXP
Dates in the story, and the Tonix Pharmaceuticals Holding (TNXP) price range
TNXP traded between 4.54 and 6.67 across 17 sessions. The latest close on file is 4.74.
How strong the case is around Tonix Pharmaceuticals Holding (TNXP)
14 out of 100
“8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.